(Press-News.org) Contact information: Shantell M. Kirkendoll
smkirk@umich.edu
734-764-2220
University of Michigan Health System
Brain imaging reveals dynamic changes caused by pain medicines
Study suggests role for brain imaging to create personalized treatment of chronic pain
ANN ARBOR, Mich. – A study in the December issue of Anesthesiology suggests a role for brain imaging in the assessment and potential treatment of chronic pain.
University of Michigan researchers are the first to use brain imaging procedures to track the clinical action of pregabalin, a drug known by the brand name Lyrica® that is prescribed to patients suffering from fibromyalgia and neuropathic pain.
Three different brain imaging procedures were performed – proton magnetic resonance spectroscopy, functional magnetic resonance imaging and functional connectivity magnetic resonance imaging – in 17 patients with fibromyalgia.
Fibromyalgia is a chronic pain disorder thought to result from a disturbance in the way the central nervous system processes pain. It affects an estimated 10 million people in the United States and 3 to 6 percent of the world population.
Patients with fibromyalgia may spontaneously report pain throughout their bodies although there is no inflammatory or anatomical damage. In addition to chronic pain, patients may also suffer from related mood disturbances, such as anxiety and depression.
Previous research has shown that fibromyalgia patients may have heightened neural activity in a region of the brain involved in processing pain and emotion called the insula, and that this excess activity may be related to elevated levels of the excitatory neurotransmitter glutamate.
Brain imaging conducted at the U-M Health System suggests pregabalin works in part by reducing the concentration of glutamate within the insula, which is consistent with animal studies. These reductions in glutamate were also accompanied by decreases in insula connectivity and reductions in clinical pain ratings.
This type of brain activity imaging may help in the development of new pain medicines and personalized chronic pain treatment.
"The significance of this study is that it demonstrates that pharmacologic therapies for chronic pain can be studied with brain imaging," says lead study author Richard Harris, Ph.D., assistant professor of anesthesiology at the University of Michigan.
"The results could point to a future in which more targeted brain imaging approaches can be used during pharmacological treatment of chronic widespread pain, rather than the current trial-and-error approach."
INFORMATION:
For more information on Anesthesiology, visit anesthesiology.org.
The American Society of Anesthesiologists
Founded in 1905, the American Society of Anesthesiologists (ASA) is an educational, research and scientific society with more than 50,000 members organized to raise and maintain the standards of the medical practice of anesthesiology. ASA is committed to ensuring physician anesthesiologists evaluate and supervise the medical care of patients before, during and after surgery to provide the highest quality and safest care every patient deserves.
Reference: "Pregabalin rectifies aberrant brain chemistry, connectivity and functional response in chronic pain patients," Vol. 119, Issue 6, December 2013, Anesthesiology, the Journal of the American Society of Anesthesiologists.
Additional authors: Vitaly Napadow, Ph.D.; John P. Huggins, Ph.D.; Lynne Pauer, M.S.; Jieun Kim, Ph.D.; Johnson Hampson, M.S.; Pia C. Sundgren, M.D.; Bradley Foerster, M.D.; Myria Petrou, M.D.; Tobias Schmidt-Wilcke, M.D.; and Daniel J. Clauw, M.D.
Funding: Pfizer Incorporated, Groton, CT
Conflicts of interest: Authors REH and DJC have previously consulted for Pfizer Inc., DJC was a consultant for Pfizer at the time of the study, and LP and JPH were employed by Pfizer and were shareholders at the time of this study.
Brain imaging reveals dynamic changes caused by pain medicines
Study suggests role for brain imaging to create personalized treatment of chronic pain
2013-11-19
ELSE PRESS RELEASES FROM THIS DATE:
Many pediatricians uncomfortable providing care to kids with genetic conditions
2013-11-19
Many pediatricians uncomfortable providing care to kids with genetic conditions
New study finds general physicians order few genetic tests, don't always discuss risks and benefits; take limited family histories
Ann Arbor, Mich. — Many primary care pediatricians ...
Natural compound mitigates effects of methamphetamine abuse, University of Missouri researchers find
2013-11-19
Natural compound mitigates effects of methamphetamine abuse, University of Missouri researchers find
COLUMBIA, Mo. – Studies have shown that resveratrol, a natural compound found in colored vegetables, fruits and especially grapes, may minimize the ...
New models predict where E. coli strains will thrive
2013-11-19
New models predict where E. coli strains will thrive
Bioengineers at the University of California, San Diego have used the genomic sequences of 55 E. coli strains to reconstruct the metabolic repertoire for each strain. Surprisingly, these reconstructions ...
UEA research reveals how farmers could mitigate nitrous oxide emissions
2013-11-19
UEA research reveals how farmers could mitigate nitrous oxide emissions
Farmers may be able to help reduce emissions of the greenhouse gas nitrous oxide (N2O) by incorporating copper into crop fertilisation processes – according to new research from the University ...
Underwater 'tree rings'
2013-11-19
Underwater 'tree rings'
Calcite crusts of arctic algae record 650 years of sea ice change
Almost 650 years of annual change in sea-ice cover can been seen in the calcite crust growth layers of seafloor algae, says a new study from the University of Toronto Mississauga ...
Among patients with recent ACS, use of enzyme inhibitor does not reduce risk of cardiovascular event
2013-11-19
Among patients with recent ACS, use of enzyme inhibitor does not reduce risk of cardiovascular event
Chicago – Stephen J. Nicholls, M.B.B.S., Ph.D., of the South Australian Health and Medical Research Institute and University of Adelaide, Adelaide, ...
In enzyme's isoforms, hope for developing heart drugs that improve contractility, prevent SCD
2013-11-19
In enzyme's isoforms, hope for developing heart drugs that improve contractility, prevent SCD
(SALT LAKE CITY)—Drugs known as PDE3 inhibitors save many lives by helping failing hearts do a better job of pumping blood. But those same medications come with ...
National study finds renal stenting does not improve outcomes for renal artery stenosis patients
2013-11-19
National study finds renal stenting does not improve outcomes for renal artery stenosis patients
Rhode Island Hospital researchers play lead roles in study; will present findings at the annual meeting of the American Heart Association
PROVIDENCE, R.I. – According to the findings ...
2 studies on the use of breast MRI
2013-11-19
2 studies on the use of breast MRI
CHICAGO – The overall use of breast magnetic resonance imaging has increased, with the procedure most commonly used for diagnostic evaluations and screenings, according to a study published by JAMA Internal Medicine, a JAMA ...
Beta-blockers before surgery appear associated with lower risk of heart-related events
2013-11-19
Beta-blockers before surgery appear associated with lower risk of heart-related events
Giving beta-blocker medication to patients with heart disease undergoing noncardiac surgery appears to be associated with a lower risk of death and major adverse cardiovascular events (MACE) ...
LAST 30 PRESS RELEASES:
Thirty-year mystery of dissonance in the “ringing” of black holes explained
Less intensive works best for agricultural soil
Arctic rivers project receives “national champion” designation from frontiers foundation
Computational biology paves the way for new ALS tests
Study offers new hope for babies born with opioid withdrawal syndrome
UT, Volkswagen Group of America celebrate research partnership
New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll
Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes
University of Cincinnati Cancer Center presents research at AACR 2025
Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025
AACR: Researchers share promising results from MD Anderson clinical trials
New research explains why our waistlines expand in middle age
Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker
Chips off the old block
Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia
Cutting the complexity from digital carpentry
Lung immune cell type “quietly” controls inflammation in COVID-19
Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity
State and sociodemographic trends in US cigarette smoking with future projections
Young adults drive historic decline in smoking
NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research
Chimpanzee stem cells offer new insights into early embryonic development
This injected protein-like polymer helps tissues heal after a heart attack
FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology
In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity
Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects
A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions
AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate
Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative
Structure dictates effectiveness, safety in nanomedicine
[Press-News.org] Brain imaging reveals dynamic changes caused by pain medicinesStudy suggests role for brain imaging to create personalized treatment of chronic pain